A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia. In addition, ...
Oct 18, 2021
0
54
(HealthDay)—For adults hospitalized with COVID-19, dexamethasone and remdesivir use increased over time, although dexamethasone is still somewhat underused, according to a study published online Aug. 17 in the Annals of ...
Aug 17, 2021
0
34
Remdesivir is an antiviral drug originally discovered as part of a program to develop antiviral agents with activity against novel emerging viruses. In the first months of the COVID-19 pandemic, it was tested as a potential ...
Aug 3, 2021
0
234
NOR-Solidarity, an independent, add-on, randomized controlled trial to the World Health Organization (WHO) Solidarity trial, found that neither remdesivir nor hydroxychloroquine (HCQ) affected viral clearance in hospitalized ...
Jul 13, 2021
0
7
Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but ...
Jul 6, 2021
0
5
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir ...
Jun 24, 2021
0
4
The virostatic agent remdesivir was developed to disrupt an important step in the propagation of RNA viruses, to which SARS-CoV-2 also belongs: the reproduction of the virus's own genetic material. This is present as RNA ...
May 10, 2021
0
4
University of Toronto physicians say more research is needed on the popular antiviral drug remdesivir, after they documented a rare case of bradycardia in a male COVID-19 patient shortly after he received the medication.
Apr 30, 2021
0
8
Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell Reports, researchers from The University of Texas at Austin, Rensselaer Polytechnic ...
Apr 27, 2021
0
196
(HealthDay)—For patients hospitalized with COVID-19, remdesivir is associated with a significant decrease in time to clinical improvement, but is not associated with a significant reduction in 28-day mortality, according ...
Mar 25, 2021
0
7
